Prognosis of 1169 hepatitis C chronically infected patients with decompensated cirrhosis in the predirect-acting antiviral era
Author:
Affiliation:
1. School of Health and Life Sciences; Glasgow Caledonian University; Glasgow UK
2. Health Protection Scotland; Glasgow UK
3. Royal Infirmary of Edinburgh; Edinburgh UK
Publisher
Wiley
Subject
Virology,Infectious Diseases,Hepatology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/jvh.12646/fullpdf
Reference32 articles.
1. Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients;Fattovich;Gastroenterology,1997
2. Effect of hepatitis B and C virus infections on the natural history of compensated cirrhosis: a cohort study of 297 patients;Fattovich;Am J Gastroenterol,2002
3. The long-term outcomes of patients with compensated hepatitis C virus-related cirrhosis and history of parenteral exposure in the united states;Hu;Hepatology,1999
4. Long-term outcome after antiviral therapy of patients with hepatitis C virus infection and decompensated cirrhosis;Iacobellis;Clin Gastroenterol Hepatol,2011
5. Peginterferon alfa-2b and ribavirin in patients with hepatitis C virus and decompensated cirrhosis: a controlled study;Iacobellis;J Hepatol,2007
Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A Machine Learning-Based Mortality Prediction Model for Patients with Chronic Hepatitis C Infection: An Exploratory Study;Journal of Clinical Medicine;2024-05-16
2. Direct-Acting Antivirals for HCV Treatment in Decompensated Liver Cirrhosis Patients: A Systematic Review and Meta-Analysis;Journal of Personalized Medicine;2022-09-15
3. Comprehensive Comparative Analysis of Standard Validated, Genetic, and Novel Biomarkers to Enhance Prognostic Risk-Stratification in Patients With Hepatitis C Virus Cirrhosis;Clinical and Translational Gastroenterology;2022-02-09
4. Uptake of interferon‐free DAA therapy among HCV‐infected decompensated cirrhosis patients and evidence for decreased mortality;Journal of Viral Hepatitis;2021-07-08
5. Clinical outcomes following DAA therapy in patients with HCV-related cirrhosis depend on disease severity;Journal of Hepatology;2021-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3